Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the

Jumpei Shoda1,2, Shigeru Tanaka1, Keishi Etori1

  • 1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Abstract

Insights

Methotrexate (MTX) treatment downregulates semaphorin 3G in rheumatoid arthritis (RA) patients. This protein exacerbates joint inflammation by increasing macrophage accumulation, suggesting a new therapeutic target for RA.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Methotrexate (MTX) is a primary treatment for rheumatoid arthritis (RA), but its exact mechanisms of action are not fully understood.
  • Identifying novel therapeutic targets is crucial for improving RA treatment outcomes.

Purpose of the Study:

  • To identify novel therapeutic target molecules affected by MTX in RA patients.
  • To investigate the role of semaphorin 3G and its receptor neuropilin-2 in RA pathogenesis.

Main Methods:

  • DNA microarray analysis of CD4+ T cells from RA patients before and after MTX treatment.
  • Evaluation of semaphorin 3G and neuropilin-2 expression in RA and osteoarthritis synovium.
  • Studies in semaphorin3G-deficient mice and in vitro analysis of macrophage behavior.

Main Results:

  • MTX treatment downregulated semaphorin 3G expression in RA patient CD4+ T cells.
  • Semaphorin 3G was upregulated in RA synovium, with its receptor neuropilin-2 on activated macrophages.
  • Semaphorin3G deficiency ameliorated arthritis models, while semaphorin 3G enhanced macrophage migration and proliferation.

Conclusions:

  • Upregulation of semaphorin 3G in the RA synovium is a novel mechanism contributing to joint inflammation.
  • Semaphorin 3G exacerbates RA by promoting macrophage accumulation, indicating its potential as a therapeutic target.

Related Concept Videos

Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
5.7K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.7K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.6K
Inflammation01:38

Inflammation

Overview
55.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K